SPG10 is a rare cause of spastic paraplegia in European families
R Schüle, BPH Kremer, J Kassubek… - Journal of Neurology …, 2008 - jnnp.bmj.com
R Schüle, BPH Kremer, J Kassubek, M Auer-Grumbach, V Kostic, T Klopstock, S Klimpe…
Journal of Neurology, Neurosurgery & Psychiatry, 2008•jnnp.bmj.comBackground: SPG10 is an autosomal dominant form of hereditary spastic paraplegia (HSP),
which is caused by mutations in the neural kinesin heavy chain KIF5A gene, the neuronal
motor of fast anterograde axonal transport. Only four mutations have been identified to date.
Objective: To determine the frequency of SPG10 in European families with HSP and to
specify the SPG10 phenotype. Patients and methods: 80 index patients from families with
autosomal dominant HSP were investigated for SPG10 mutations by direct sequencing of …
which is caused by mutations in the neural kinesin heavy chain KIF5A gene, the neuronal
motor of fast anterograde axonal transport. Only four mutations have been identified to date.
Objective: To determine the frequency of SPG10 in European families with HSP and to
specify the SPG10 phenotype. Patients and methods: 80 index patients from families with
autosomal dominant HSP were investigated for SPG10 mutations by direct sequencing of …
Background
SPG10 is an autosomal dominant form of hereditary spastic paraplegia (HSP), which is caused by mutations in the neural kinesin heavy chain KIF5A gene, the neuronal motor of fast anterograde axonal transport. Only four mutations have been identified to date.
Objective
To determine the frequency of SPG10 in European families with HSP and to specify the SPG10 phenotype.
Patients and methods
80 index patients from families with autosomal dominant HSP were investigated for SPG10 mutations by direct sequencing of the KIF5A motor domain. Additionally, the whole gene was sequenced in 20 of these families.
Results
Three novel KIF5A mutations were detected in German families, including one missense mutation (c.759G>T, p.K253N), one in frame deletion (c.768_770delCAA, p.N256del) and one splice site mutation (c.217G>A). Onset of gait disturbance varied from infancy to 30 years of age. All patients presented clinically with pure HSP, but a subclinical sensory–motor neuropathy was detected by neurophysiology studies.
Conclusions
SPG10 accounts for approximately 3% of European autosomal dominant HSP families. All mutations affect the motor domain of kinesin and thus most likely impair axonal transport. Clinically, SPG10 is characterised by spastic paraplegia with mostly subclinical peripheral neuropathy.
jnnp.bmj.com
